_bristol-myers-squibb-to-buy-karuna-therapeutics-for-3614-billion-in-cash-preview-1.jpg "Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion in cash from bms investor slides Video Screenshot Preview 1")
Gallery_bristol-myers-squibb-to-buy-karuna-therapeutics-for-3614-billion-in-cash-preview-3.jpg "Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion in cash from bms investor slides Video Screenshot Preview 3")
Gallery_bristol-myers-squibb-to-buy-karuna-therapeutics-for-3614-billion-in-cash-preview-hqdefault.jpg "Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion in cash from bms investor slides Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 42 seconds
👁 View: 3.7K times
Play Audio:👁 View: 3.7K times
Description:
CNBC Television
CNBC Television
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_bmy-is-crashing-to-a-52-week-low-124-massive-upside-124-bmy-bristol-myers-squibb-stock-analysis-124.webp "Dividend Talks")
⏲ 19 minutes 16 seconds 👁 4.9K
_biotech-boom-ahead-in-2024-top-jefferies-analyst-predicts-on-heels-of-bristol-meyers-karuna-deal.webp "CNBC Television")
⏲ 5 minutes 52 seconds 👁 20K
_3610-billion-in-free-cash-flow-8-yield-bristol-myers-squibb-company-36bmy-stock-to-own-in-2024.webp "Rational Investing with Cameron Stewart, CFA")
$10 Billion in Free Cash Flow, 8% Yield - Bristol-Myers Squibb Company ($BMY) - Stock to own in 2024
⏲ 20 minutes 25 seconds 👁 8K
_bristol-myers-squibb-to-buy-karuna-therapeutics-for-3614-billion-in-cash.webp "CNBC Television")
_bristol-myers-stock-analysis-risks-amp-upside-potential124-bmy.webp "The Patient Investor")
_the-state-of-pharmaceuticals-bristol-myers-squibb39s-plan-to-buy-rayzebio.webp "CNBC Television")
⏲ 2 minutes 46 seconds 👁 2.1K
_bristol-myers-ceo-says-the-company-is-in-transition.webp "Bloomberg Television")
_bristol-myers-squibb-ceo-we-are-on-track-to-continue-delivering-growth.webp "CNBC Television")
_bmy-is-crashing-to-a-52-week-low-124-massive-upside-124-bmy-bristol-myers-squibb-stock-analysis-124.jpg)
_biotech-boom-ahead-in-2024-top-jefferies-analyst-predicts-on-heels-of-bristol-meyers-karuna-deal.jpg)
_3610-billion-in-free-cash-flow-8-yield-bristol-myers-squibb-company-36bmy-stock-to-own-in-2024.jpg)
_bristol-myers-squibb-to-buy-karuna-therapeutics-for-3614-billion-in-cash.jpg)
_bristol-myers-stock-analysis-risks-amp-upside-potential124-bmy.jpg)
_the-state-of-pharmaceuticals-bristol-myers-squibb39s-plan-to-buy-rayzebio.jpg)
_bristol-myers-ceo-says-the-company-is-in-transition.jpg)
_bristol-myers-squibb-ceo-we-are-on-track-to-continue-delivering-growth.jpg)
![[+]](/images/menu.gif){kind=small}